K

Active Director Director DIN 08830397
DIN 08830397 First appointment Aug 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Karamjit

Data last updated:

Karamjit is a Director at Medrix Labs Private Limited (since 2020). The company operates in Pharma. Medrix Labs Private Limited reported revenue of ₹3.63 Cr (FY 2024).

DIN 08830397
Primary Designation Director
Industry Pharma
First Appointment 11 Aug 2020
Oldest Company Age 6 yrs
Largest company Medrix Labs Private Limited · ₹3.63 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medrix Labs Private Limited U24290PB2020PTC051613
Director11 Aug 20202020₹3.63 Cr (FY 2024)Active

Board colleagues of Karamjit

NameDINCompanyDesignation
Rohit Sharma03585803Medrix Labs Private LimitedDirector
Vikram Arora11084895Medrix Labs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medrix Labs Private Limited
Premium access

Shareholding and investment profile for Karamjit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karamjit

Karamjit currently holds 1 directorship: Medrix Labs Private Limited (Director, since 11 Aug 2020, revenue ₹3.63 Cr (FY 2024)).

Karamjit was first appointed on 11 Aug 2020 as Director at Medrix Labs Private Limited.

The current boards of Karamjit's companies include Rohit Sharma (Medrix Labs Private Limited), Vikram Arora (Medrix Labs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available